2027, Diabetes and Drug Pricing

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2027

Diabetes

Drug Pricing

STAT+: Wegovy is among drugs set to be targeted in the next round of Medicare price negotiations, researchers say

STAT

SEPTEMBER 23, 2024

Now, all eyes are on which Part D drugs will be chosen for the next round of 15 drugs. 1, and the negotiated prices of those drugs take effect in 2027. Wegovy contains the same active ingredient, semaglutide, as Ozempic and Rybelsus, which help manage blood sugar levels in people with type 2 diabetes.

Specialty Pharmacies

Specialty Pharmacies Diabetes Drug Pricing

NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027

Putting Patients First Blog

JULY 2, 2024

General Comments The NHC appreciates CMS’ commitment to actively engaging with stakeholders, including patients, consumer advocates, and health experts, in implementing the Medicare Drug Price Negotiation Program (DPNP). Valuing life differently based on disability status, age, or other special populations is inappropriate.

Drug Pricing

Drug Pricing Insurance Coverage and Processing HIPAA Labelling

Webinars

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

MORE WEBINARS

Pharmacist Digest

STAT+: Wegovy is among drugs set to be targeted in the next round of Medicare price negotiations, researchers say

NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027

Webinars

Stay Connected